Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
CRDL.TO - Cardiol Therapeutics Inc
Cardiol Therapeutics Inc at TD Cowen Healthcare Conference
Mar 04, 2026 / 03:30PM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning. It's a pleasure to Speak about our important work in heart disease.
Cardiotherapeutics is focused on targeting a key disease causing mechanism, which is inflammation in the heart disease landscape. We have important orphan drug indications in advanced stage development, and we also have earlier stage developments addressing much larger challenges in heart disease, which is heart failure, which is a A growing and very significant impact on human health and medicine for challenges.
I think the key features of cardiology is the late stage program, which is the Maverick study, which is targeting inflammation and recurrent pericarditis. We see a very exciting opportunity in this area of
Trustpilot
